Privacy Policy
Signals Blog

Contributors

Categories

Update from the Clinic: August

. Welcome to your Update from the Clinic for the month of August. Asterias Biotherapeutics breathes new life into a cell therapy shelved two years ago and initiates a Phase I/II study in patients with spinal cord injury. Northwest Biotherapeutics provides an update on...

Life, death and regulation

. With contributions from James Smith, a recent Oxford University graduate and current SENS Research Foundation Summer Scholar working at the Harvard Stem Cell Institute.   Consider this question: if I gave you the option to take a drug offering a 100 percent chance...

Careful with the heart strings: Promise vs. potential

> The cellular therapy plenary at the ISSCR conference on June 19 was an incredibly interesting mix of hope and despair. On one hand, the opening talk by Leigh Turner made us imagine thousands of people in the United States getting duped into stem cell therapies as...

Right Turn: Things you should know before ISSCR

. What’s small and blue and brings a smile to your face? No, not a Smurf and I’m not talking about a little blue pill either. It’s the little cartoon guy from Life Technologies and he has a mission for those who are ISSCR-bound (and even those who aren’t). Watch him...